Antonio Carrascosa

The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.

H. Wollmann, M. Fernández-Cancio, M. Clemente, 2006, The Journal of clinical endocrinology and metabolism.

Personalized Approach to Growth Hormone Treatment: Clinical Use of Growth Prediction Models

S. van Buuren, P. Clayton, J. Wit, 2013, Hormone Research in Paediatrics.

Height Gain at Adult-Height Age in 184 Short Patients Treated with Growth Hormone from Prepubertal Age to Near Adult-Height Age is Not Related to GH Secretory Status at GH Therapy Onset

M. Fernández-Cancio, M. Clemente, M. Gussinyé, 2013, Hormone Research in Paediatrics.

Growth Hormone Secretory Status Evaluated by Growth Hormone Peak after Two Pharmacological Growth Hormone Release Stimuli Did Not Significantly Influence the Two-Year Catch-Up Growth Induced by Growth Hormone Therapy in 318 Prepubertal Short Children with Idiopathic Growth Retardation

M. Fernández-Cancio, M. Clemente, M. Gussinyé, 2010, Hormone Research in Paediatrics.